Search Clinical Trials
598,375 trials
ID
Status
Phase
Title
Sponsor
NCT07766109
Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac SurgeryUniversity Hospital, ToulouseNot Yet RecruitingPhase 4
NCT07766109Not Yet Recruiting
Phase 4
Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac SurgeryUniversity Hospital, Toul...
NCT07765667
NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARCSixth Affiliated Hospital, Sun Yat-sen UniversityNot Yet RecruitingPhase 2
NCT07765667Not Yet Recruiting
Phase 2
NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARCSixth Affiliated Hospital...
NCT07764978
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTAstraZenecaRecruitingPhase 3
NCT07764978Recruiting
Phase 3
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTAstraZeneca
NCT07765797
Development and Validation of a Scale of Propensity for Change in Chronic Disease PreventionUniversity Hospital, ToulouseNot Yet Recruiting
NCT07765797Not Yet Recruiting
—
Development and Validation of a Scale of Propensity for Change in Chronic Diseas...University Hospital, Toul...
NCT07764783
Visual Instillation of Sphenopalatine-block Intervention for ONgoing MigraineAssociation of Migraine DisordersNot Yet RecruitingPhase 2
NCT07764783Not Yet Recruiting
Phase 2
Visual Instillation of Sphenopalatine-block Intervention for ONgoing MigraineAssociation of Migraine D...
NCT07766772
Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast CancerFujian Cancer HospitalNot Yet RecruitingPhase 2
NCT07766772Not Yet Recruiting
Phase 2
Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capec...Fujian Cancer Hospital
NCT07764874
Unilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS in Advanced Parkinson's Disease.InSightecNot Yet RecruitingNot Applicable
NCT07764874Not Yet Recruiting
Not Applicable
Unilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS...InSightec
NCT07766499
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy and Safety of THB335 in Adult Participants With Chronic Spontaneous Urticaria (CSU)Calixis Inc.Not Yet RecruitingPhase 2
NCT07766499Not Yet Recruiting
Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multice...Calixis Inc.
NCT07765940
Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate CancerRadAlliance Therapeutics, IncNot Yet RecruitingPhase 1
NCT07765940Not Yet Recruiting
Phase 1
Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Can...RadAlliance Therapeutics,...
NCT07765654
WhatsApp Messages to Improve Mothers' Oral Health Knowledge and Children's ToothbrushingKing Abdulaziz UniversityNot Yet RecruitingNot Applicable
NCT07765654Not Yet Recruiting
Not Applicable
WhatsApp Messages to Improve Mothers' Oral Health Knowledge and Children's Tooth...King Abdulaziz University
NCT07766590
Magnesium Oxide and Letrozole Versus Letrozole Alone on Ovarian Response in Insulin Resistant PCOSBangladesh Medical UniversityCompletedNot Applicable
NCT07766590Completed
Not Applicable
Magnesium Oxide and Letrozole Versus Letrozole Alone on Ovarian Response in Insu...Bangladesh Medical Univer...
NCT07766460
Predictive Factors for a Positive Exercise Bronchial Hyperresponsiveness TestCentral Hospital, Nancy, FranceCompleted
NCT07766460Completed
—
Predictive Factors for a Positive Exercise Bronchial Hyperresponsiveness TestCentral Hospital, Nancy,...
NCT07766278
Urine Collection and Novel UTI Biomarkers in Children and Older AdultsQueen's University, BelfastNot Yet Recruiting
NCT07766278Not Yet Recruiting
—
Urine Collection and Novel UTI Biomarkers in Children and Older AdultsQueen's University, Belfa...
NCT07764679
A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine InjectionHTA Co., Ltd.RecruitingPhase 3
NCT07764679Recruiting
Phase 3
A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the...HTA Co., Ltd.
NCT07765147
Evaluating iCare COMPASS as a Visual Field Diagnostic ToolIndiana UniversityCompletedNot Applicable
NCT07765147Completed
Not Applicable
Evaluating iCare COMPASS as a Visual Field Diagnostic ToolIndiana University
NCT07766694
Evaluating the Preferences and Tradeoffs of AI-based Electronic Consultations for Older Adults in Primary CareUniversity of PennsylvaniaNot Yet RecruitingNot Applicable
NCT07766694Not Yet Recruiting
Not Applicable
Evaluating the Preferences and Tradeoffs of AI-based Electronic Consultations fo...University of Pennsylvani...
NCT07766486
Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation TherapyFondazione del Piemonte per l'OncologiaActive Not RecruitingNot Applicable
NCT07766486Active Not Recruiting
Not Applicable
Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormo...Fondazione del Piemonte p...
NCT07765160
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese ParticipantsInnovent Biologics (Suzhou) Co. Ltd.Not Yet RecruitingPhase 1
NCT07765160Not Yet Recruiting
Phase 1
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Parti...Innovent Biologics (Suzho...
NCT07765199
Blood'up Device Versus Manual Palpation for Arterial Puncture in Healthy Volunteers: A Pilot Randomized Study Under Normal and Simulated HypotensionCentre Hospitalier Régional d'OrléansNot Yet RecruitingNot Applicable
NCT07765199Not Yet Recruiting
Not Applicable
Blood'up Device Versus Manual Palpation for Arterial Puncture in Healthy Volunte...Centre Hospitalier Région...
Result Breakdown
Not yet recruiting13 (65%)
Recruiting3 (15%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable7 (35%)
Phase 25 (25%)
Not Specified3 (15%)
Phase 32 (10%)
Phase 12 (10%)
Phase 41 (5%)